These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 20012574

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identification of potent pyrazolo[4,3-h]quinazoline-3-carboxamides as multi-cyclin-dependent kinase inhibitors.
    Traquandi G, Ciomei M, Ballinari D, Casale E, Colombo N, Croci V, Fiorentini F, Isacchi A, Longo A, Mercurio C, Panzeri A, Pastori W, Pevarello P, Volpi D, Roussel P, Vulpetti A, Brasca MG.
    J Med Chem; 2010 Mar 11; 53(5):2171-87. PubMed ID: 20141146
    [Abstract] [Full Text] [Related]

  • 8. SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples.
    Conroy A, Stockett DE, Walker D, Arkin MR, Hoch U, Fox JA, Hawtin RE.
    Cancer Chemother Pharmacol; 2009 Sep 11; 64(4):723-32. PubMed ID: 19169685
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15.
    Iavarone A, Massagué J.
    Nature; 1997 May 22; 387(6631):417-22. PubMed ID: 9163429
    [Abstract] [Full Text] [Related]

  • 11. Anticancer activity and differentially expressed genes in head and neck cancer cells treated with a novel cyclin-dependent kinase inhibitor.
    Shin HC, Song DW, Baek WK, Lee SR, Kwon TK, Lee J, Park SH, Jang BC, Park JW.
    Chemotherapy; 2009 May 22; 55(5):353-62. PubMed ID: 19657189
    [Abstract] [Full Text] [Related]

  • 12. The roles and therapeutic potential of cyclin-dependent kinases (CDKs) in sarcoma.
    Liao Y, Feng Y, Shen J, Hornicek FJ, Duan Z.
    Cancer Metastasis Rev; 2016 Jun 22; 35(2):151-63. PubMed ID: 26669603
    [Abstract] [Full Text] [Related]

  • 13. Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers.
    Santo L, Siu KT, Raje N.
    Semin Oncol; 2015 Dec 22; 42(6):788-800. PubMed ID: 26615126
    [Abstract] [Full Text] [Related]

  • 14. Cyclin-dependent kinases: bridging their structure and function through computations.
    De Vivo M, Bottegoni G, Berteotti A, Recanatini M, Gervasio FL, Cavalli A.
    Future Med Chem; 2011 Sep 22; 3(12):1551-9. PubMed ID: 21882947
    [Abstract] [Full Text] [Related]

  • 15. Investigational drugs targeting cyclin-dependent kinases for the treatment of cancer: an update on recent findings (2013-2016).
    Di Giovanni C, Novellino E, Chilin A, Lavecchia A, Marzaro G.
    Expert Opin Investig Drugs; 2016 Oct 22; 25(10):1215-30. PubMed ID: 27606939
    [Abstract] [Full Text] [Related]

  • 16. Small Molecule CDK Inhibitors for the Therapeutic Management of Cancer.
    Goel B, Tripathi N, Bhardwaj N, Jain SK.
    Curr Top Med Chem; 2020 Oct 22; 20(17):1535-1563. PubMed ID: 32416692
    [Abstract] [Full Text] [Related]

  • 17. Dissecting the Pol II transcription cycle and derailing cancer with CDK inhibitors.
    Parua PK, Fisher RP.
    Nat Chem Biol; 2020 Jul 22; 16(7):716-724. PubMed ID: 32572259
    [Abstract] [Full Text] [Related]

  • 18. Potential Clinical Uses of CDK Inhibitors: Lessons from Synthetic Lethality Screens.
    Vymětalová L, Kryštof V.
    Med Res Rev; 2015 Nov 22; 35(6):1156-74. PubMed ID: 26114963
    [Abstract] [Full Text] [Related]

  • 19. Inhibitors of cyclin-dependent kinases as cancer therapeutics.
    Whittaker SR, Mallinger A, Workman P, Clarke PA.
    Pharmacol Ther; 2017 May 22; 173():83-105. PubMed ID: 28174091
    [Abstract] [Full Text] [Related]

  • 20. Cell cycle, CDKs and cancer: a changing paradigm.
    Malumbres M, Barbacid M.
    Nat Rev Cancer; 2009 Mar 22; 9(3):153-66. PubMed ID: 19238148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.